These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 10839701)
1. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner. Eltabbakh GH; Eltabbakh GD J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701 [TBL] [Abstract][Full Text] [Related]
5. The current status of the Papanicolaou smear. Shingleton HM; Patrick RL; Johnston WW; Smith RA CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133 [TBL] [Abstract][Full Text] [Related]
6. No increased risk for cervical cancer after a broader definition of a negative Pap smear. Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046 [TBL] [Abstract][Full Text] [Related]
7. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan. Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029 [TBL] [Abstract][Full Text] [Related]
8. Update on the Papanicolaou smear: new issues for the 1990s. Ollayos CW Mil Med; 1997 Aug; 162(8):521-3. PubMed ID: 9271901 [TBL] [Abstract][Full Text] [Related]
9. Present standards for cervical cancer screening. O'Meara AT Curr Opin Oncol; 2002 Sep; 14(5):505-11. PubMed ID: 12192269 [TBL] [Abstract][Full Text] [Related]
10. Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Kanber Y; Charbonneau M; Auger M Cancer Cytopathol; 2015 Dec; 123(12):739-44. PubMed ID: 26348845 [TBL] [Abstract][Full Text] [Related]
11. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations. Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673 [TBL] [Abstract][Full Text] [Related]
12. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process. Renshaw AA; DiNisco SA; Minter LJ; Cibas ES Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513 [TBL] [Abstract][Full Text] [Related]
13. Pap smears. Still a reliable screening tool for cervical cancer. Stack PS Postgrad Med; 1997 Apr; 101(4):207-8, 211-4. PubMed ID: 9126213 [TBL] [Abstract][Full Text] [Related]
15. Pap smears. Do them right and every year--forever! Gall SA Postgrad Med; 1989 May; 85(6):235-9. PubMed ID: 2710727 [TBL] [Abstract][Full Text] [Related]
16. The postpartum Papanicolaou smear. Weiss BD; Senf JH; Udall W J Am Board Fam Pract; 1989; 2(1):4-9. PubMed ID: 2538045 [TBL] [Abstract][Full Text] [Related]
17. Current use of the Papanicolaou smear. Crump WJ J Am Board Fam Pract; 1988; 1(2):131-4. PubMed ID: 3414395 [TBL] [Abstract][Full Text] [Related]
18. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system. Marshall CJ; Rowe L; Bentz JS Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244 [TBL] [Abstract][Full Text] [Related]
19. Pap smear intervals safe. AIDS Patient Care STDS; 2000 Dec; 14(12):675. PubMed ID: 11119436 [No Abstract] [Full Text] [Related]
20. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]